Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
OneMedNet Corporation is a healthcare technology company focused on the curation, de-identification, and commercialization of real-world medical imaging data and associated clinical information. The company operates at the intersection of healthcare data services, medical imaging, and life sciences analytics, providing data solutions primarily to pharmaceutical companies, medical device manufacturers, artificial intelligence developers, and academic researchers.
The company’s core offering centers on its proprietary platform for imaging real-world data, often referred to as imaging RWD, which enables customers to access large-scale, regulatory-grade datasets for research, development, and post-market surveillance. OneMedNet traces its origins to earlier healthcare data initiatives and became a publicly traded company in 2023 through a business combination, positioning itself as a specialized data infrastructure provider within the broader real-world evidence market.
Business Operations
OneMedNet generates revenue primarily through data licensing and subscription-based access to its imaging data marketplace, which aggregates and standardizes medical imaging studies and related clinical metadata from healthcare providers. Its principal operating activity is the operation of the OneMedNet iRWD Platform, which facilitates data ingestion, de-identification, compliance workflows, and distribution to commercial and research customers.
Operations include both domestic and international data sourcing, with healthcare provider partners contributing imaging studies across multiple modalities. The company controls its proprietary data processing technology and compliance framework, which are designed to meet regulatory and privacy standards. Public disclosures indicate reliance on a network of provider relationships rather than ownership of physical imaging assets, and there is limited publicly available information confirming material joint ventures; data on certain partnership arrangements is inconclusive based on available public sources.
Strategic Position & Investments
Strategically, OneMedNet is focused on expanding its role in the growing demand for real-world evidence, particularly imaging-centric datasets used in drug development, regulatory submissions, and artificial intelligence model training. Growth initiatives include increasing the scale and diversity of its imaging database, expanding use cases in life sciences research, and deepening relationships with pharmaceutical and medical technology companies.
The company has emphasized investment in data standardization, regulatory alignment, and platform scalability rather than large-scale acquisitions. Public filings indicate no significant acquisitions of operating businesses to date, and information on minority investments or portfolio holdings beyond core operations is limited. Engagement with emerging technologies, particularly AI-enabled medical imaging analytics, is a stated strategic priority, though commercialization timelines remain dependent on market adoption.
Geographic Footprint
OneMedNet is headquartered in the United States and primarily operates within the North American healthcare market. Its provider network and customer base are largely U.S.-focused, reflecting the regulatory and reimbursement structures that underpin its data offerings.
Internationally, the company has indicated access to imaging data sourced from select non-U.S. regions, supporting global life sciences research needs. However, there is limited public disclosure detailing the scale of operations or dedicated infrastructure outside North America, and the extent of international operational influence cannot be conclusively verified from available public sources.
Leadership & Governance
OneMedNet is led by an executive team with backgrounds in healthcare data, life sciences, and technology-enabled services. Leadership has articulated a strategy centered on regulatory-grade data quality, compliance, and long-term partnerships with life sciences customers.
Key executives include:
- Aaron Green – President & Chief Executive Officer
- Howard S. Weinstein – Chairman of the Board
- Michael Wong – Chief Technology Officer
Public disclosures provide limited detail on additional senior executives and governance committee structures, and information regarding broader executive leadership beyond those listed above is inconclusive based on available public sources.